Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dendritic Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02766348
What this trial is testing

Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients

Who this might be right for
NSCLC
Shenzhen Hornetcorn Bio-technology Company, LTD 60
Not applicableEnded earlyNCT00897910
What this trial is testing

Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 6
Early research (Phase 1)Study completedNCT01241682
What this trial is testing

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma

Who this might be right for
Malignant (Pleural) Mesothelioma
Erasmus Medical Center 10
Early research (Phase 1)Active Not RecruitingNCT04013685
What this trial is testing

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMyelodysplastic Syndromes+3 more
Orca Biosystems, Inc. 155
Testing effectiveness (Phase 2)Active Not RecruitingNCT05261750
What this trial is testing

Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
PT. Prodia Stem Cell Indonesia 15
Early research (Phase 1)Study completedNCT00796770
What this trial is testing

Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)

Who this might be right for
HIV
Baylor Research Institute 19
Testing effectiveness (Phase 2)UnknownNCT01839539
What this trial is testing

Study of DC-CIK to Treat Colorectal Cancer

Who this might be right for
Colorectal Cancer
Guangxi Medical University 60
Early research (Phase 1)Study completedNCT00005988
What this trial is testing

Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Dana-Farber Cancer Institute 5
Early research (Phase 1)Study completedNCT00856154
What this trial is testing

Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection

Who this might be right for
HIV Infections
Statens Serum Institut 12
Early research (Phase 1)Ended earlyNCT02548169
What this trial is testing

Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Baylor Research Institute 7
Testing effectiveness (Phase 2)Study completedNCT01676779
What this trial is testing

MRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Universitair Ziekenhuis Brussel 88
Testing effectiveness (Phase 2)Ended earlyNCT00295880
What this trial is testing

Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+1 more
Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Study completedNCT00893945
What this trial is testing

Autologous Dendritic Cells Pulsed With Autologous Apoptotic Tumor Cells Administered to Patients With Brain Tumors

Who this might be right for
Brain Tumors
Rockefeller University 19
Large-scale testing (Phase 3)Study completedNCT00265837
What this trial is testing

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Very early researchUnknownNCT03214939
What this trial is testing

Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Research Institute of Fundamental and Clinical Immunology 30
Testing effectiveness (Phase 2)Ended earlyNCT04342962
What this trial is testing

Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 25
Not applicableStudy completedNCT02525042
What this trial is testing

Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach

Who this might be right for
Ankylosing Spondylitis
Assistance Publique - Hôpitaux de Paris 97
Testing effectiveness (Phase 2)Study completedNCT02334735
What this trial is testing

A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence

Who this might be right for
Melanoma
Nina Bhardwaj 36
Testing effectiveness (Phase 2)Study completedNCT03349450
What this trial is testing

DPX-Survivac and Checkpoint Inhibitor in DLBCL

Who this might be right for
Adult Diffuse Large Cell LymphomaRecurrentAdult Refractory Diffuse Large B-Cell Lymphoma
Sunnybrook Health Sciences Centre 25
Not applicableLooking for participantsNCT07785180
What this trial is testing

A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc. 140
Next Page